Semaglutide Side-Chain Modification-Related Impurity Reference Material
Side-chain modification impurities may affect receptor binding, pharmacokinetics, and immunogenicity. Analytical reference materials are required for complete impurity profiling.
PARENT PEPTIDE
Semaglutide
MATERIAL TYPE
Side-Chain Related Impurity
TARGET PURITY
≥85% (HPLC)
EVIDENCE STATUS
PeptiQore Experimental
QUANTITY
DOCUMENTATION
QUALITY CONTEXT
Why This Record Matters
The lipidated fatty acid side chain of Semaglutide introduces a category of modification-related impurities with significant analytical and commercial relevance. Specific variants to be selected based on technical team assessment.
POTENTIAL ORIGIN
Incomplete or aberrant fatty acid conjugation, linker modification, or side-chain degradation during synthesis or storage.
Analytical Data Package
PEPTIQORE APPROACH
TRADITIONAL SUPPLIER
Product → CoA
IMPURITY CLASSIFICATION
Side-Chain Related ImpurityEVIDENCE STATUS
PeptiQore ExperimentalPARENT PEPTIDE
Semaglutide Quality Hub →RELATED ANALYTICAL MATERIALS
CUSTOM DEVELOPMENT
Can't Find Your Impurity?
PeptiQore supports custom development of peptide-related impurities, sequence variants and degradation materials.